AR020741A1 - Composicion y metodo para tratar enfermedades alergicas - Google Patents

Composicion y metodo para tratar enfermedades alergicas

Info

Publication number
AR020741A1
AR020741A1 ARP990105083A ARP990105083A AR020741A1 AR 020741 A1 AR020741 A1 AR 020741A1 AR P990105083 A ARP990105083 A AR P990105083A AR P990105083 A ARP990105083 A AR P990105083A AR 020741 A1 AR020741 A1 AR 020741A1
Authority
AR
Argentina
Prior art keywords
composition
allergic diseases
treat allergic
effective amount
treat
Prior art date
Application number
ARP990105083A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR020741A1 publication Critical patent/AR020741A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composicion farmacéutica util para el tratamiento de la rinitis alérgica, el asma y trastornos relacionados. En una realizacion, la composicion comprende,en combinacion, una cantidad terapéuticamente efectiva de al menos un antagonista deneuroquinin a, una cantidad efectiva de al menos un inhibidor de5-lipoxigenasa.
ARP990105083A 1998-10-09 1999-10-07 Composicion y metodo para tratar enfermedades alergicas AR020741A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16960998A 1998-10-09 1998-10-09

Publications (1)

Publication Number Publication Date
AR020741A1 true AR020741A1 (es) 2002-05-29

Family

ID=22616408

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105083A AR020741A1 (es) 1998-10-09 1999-10-07 Composicion y metodo para tratar enfermedades alergicas

Country Status (9)

Country Link
EP (1) EP1119372A1 (es)
JP (1) JP2002527406A (es)
CN (1) CN1329505A (es)
AR (1) AR020741A1 (es)
AU (1) AU6391199A (es)
CA (1) CA2346228A1 (es)
CO (1) CO5140080A1 (es)
PE (1) PE20001095A1 (es)
WO (1) WO2000021564A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1633357A4 (en) * 2003-04-15 2010-02-10 Merck & Co Inc MONTELUKAST SODIUM POLYMORPHIC SHAPE
EP1997491B1 (en) * 2004-07-14 2010-09-22 Inflammation Research Center Company Ltd. Method for inhibiting tumor metastasis
AU2008208920A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or R(-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an NK1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9415997D0 (en) * 1994-08-08 1994-09-28 Merck Sharp & Dohme Therapeutic agents
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CN1329505A (zh) 2002-01-02
CA2346228A1 (en) 2000-04-20
WO2000021564A1 (en) 2000-04-20
AU6391199A (en) 2000-05-01
PE20001095A1 (es) 2000-10-31
CO5140080A1 (es) 2002-03-22
JP2002527406A (ja) 2002-08-27
EP1119372A1 (en) 2001-08-01

Similar Documents

Publication Publication Date Title
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
DE69529912D1 (de) Verwendung des sekretorischen leukozytaren protease inhibitors (slpi) als tryptase-inhibitor
MY134110A (en) Combinations of reboxetine and neuroleptic agents
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
EP1769797A3 (en) Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition
AR025923A1 (es) Nueva combinacion de loteprednol y antihistaminicos
DE602004012418D1 (de) Piperazinderivate und anwendungsverfahren
AR020740A1 (es) Composicion y metodo para tratar enfermedades alergicas
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
AR020741A1 (es) Composicion y metodo para tratar enfermedades alergicas
WO2003051290A3 (en) Treating b-cell mediated diseases by modulating dr6 activity
BG106748A (en) Method and compositions for treating pulmonary diseases
PT1071463E (pt) Metodos e composicoes utilizando metabolitos de terfenadina em combinacao com inibidores de leucotrieno
AR019327A1 (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
ECSP993167A (es) Composicion y metodo para tratar enfermedades alergicas
ECSP993168A (es) Composicion y metodo para tratar enfermedades alergicas
NO20053247D0 (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
WO2000054770A8 (en) Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
AR018825A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas

Legal Events

Date Code Title Description
FB Suspension of granting procedure